| Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible? YM Jacobo-Delgado, A Rodríguez-Carlos, CJ Serrano, B Rivas-Santiago Frontiers in immunology 14, 1194923, 2023 | 25 | 2023 |
| Steroid hormone modulates the production of cathelicidin and human β-defensins in lung epithelial cells and macrophages promoting Mycobacterium tuberculosis killing SP Marin-Luevano, A Rodriguez-Carlos, Y Jacobo-Delgado, ... Tuberculosis 128, 102080, 2021 | 21 | 2021 |
| Modulation of cathelicidin and defensins by histone deacetylase inhibitors: A potential treatment for multi-drug resistant infectious diseases A Rodríguez-Carlos, YM Jacobo-Delgado, AO Santos-Mena, ... Peptides 140, 170527, 2021 | 19 | 2021 |
| Retinoic acid induces antimicrobial peptides and cytokines leading to Mycobacterium tuberculosis elimination in airway epithelial cells YM Jacobo-Delgado, F Torres-Juarez, A Rodríguez-Carlos, ... Peptides 142, 170580, 2021 | 9 | 2021 |
| Are host defense peptides and their derivatives ready to be part of the treatment of the next coronavirus pandemic? B Rivas-Santiago, Y Jacobo-Delgado, A Rodriguez-Carlos Archivum Immunologiae et Therapiae Experimentalis 69 (1), 25, 2021 | 5 | 2021 |
| Potential use of liposomes in tuberculosis treatment YM Jacobo-Delgado, G Navarro-Tovar, B Rivas-Santiago Revista Medica del Instituto Mexicano del Seguro Social 61 (5), 661-669, 2023 | 2 | 2023 |
| Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR … A Rodríguez-Carlos, Y Jacobo-Delgado, AO Santos-Mena, ... Memórias do Instituto Oswaldo Cruz 118, e230143, 2023 | 1 | 2023 |
| Nicotine associates to intracellular Mycobacterium tuberculosis inducing genes related with resistance to antimicrobial peptides J de Haro-Acosta, YM Jacobo-Delgado, A Rodríguez-Carlos, ... Experimental Lung Research 47 (10), 487-493, 2021 | 1 | 2021 |
| Metformin modulates corticosteroids hormones in adrenals cells promoting Mycobacterium tuberculosis elimination in human macrophages OE Gonzalez-Muñiz, A Rodriguez-Carlos, A Santos-Mena, ... Tuberculosis 148, 102548, 2024 | | 2024 |
| The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study AM Tovar-Nieto, LE Flores-Padilla, B Rivas-Santiago, JV Trujillo-Paez, ... Microorganisms 12 (8), 1505, 2024 | | 2024 |
| Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection A Rodriguez-Carlos, A Raúl, YM Jacobo-Delgado, CJ Serrano, ... Canadian Journal of Microbiology, 2024 | | 2024 |
| Shedding Light on Vitamin D in Tuberculosis: A Comprehensive Review of Clinical Trials and Discrepancies A Santos-Mena, OE González-Muñiz, YM Jacobo-Delgado, ... Pulmonary Pharmacology & Therapeutics, 102300, 2024 | | 2024 |
| Modulación de la inmunidad innata y adaptativa por hormonas adrenales en enfermedades infecciosas: tuberculosis OE González-Muñiz, YM Jacobo-Delgado, C Félix-Arellano, CJ Serrano, ... TIP Revista Especializada en Ciencias Químico-Biológicas 27, 2024 | | 2024 |
| Uso potencial de liposomas en el tratamiento contra la tuberculosis YM Jacobo-Delgado, G Navarro-Tovar, B Rivas-Santiago Revista Médica del Instituto Mexicano del Seguro Social 61 (5), 661, 2023 | | 2023 |
| Evaluación de la vía independiente de VDR para la inducción de LL-37 en la infección con Mycobacterium tuberculosis YM Jacobo Delgado REPOSITORIO NACIONAL CONACYT, 2021 | | 2021 |
